Sign Up Today and Learn More About Bright Peak Therapeutics Stock

Invest in or calculate the value of your shares in Bright Peak Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

Bright Peak Therapeutics Stock

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

About Bright Peak Therapeutics Stock

Founded

2017

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. The company's immunotherapies allow tissue and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy.

Bright Peak Therapeutics Management

Leadership team at Bright Peak Therapeutics

Co-Founder, Senior Vice President & Head of Technology

Vijaya Pattabiraman

Co-Founder & Scientific Advisor

Jeffrey Bode

Locked Features

Join now and verify your accreditation status to gain access to:

  • Bright Peak Therapeutics current valuation
  • Bright Peak Therapeutics stock price
  • Available deals in Bright Peak Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Bright Peak Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like Bright Peak Therapeutics through EquityZen funds. These investments are made available by existing Bright Peak Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Bright Peak Therapeutics stock?

Shareholders can sell their Bright Peak Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."